Mark Sheptoff Financial Planning’s Pasithea Therapeutics KTTA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-166	Closed	-$1.59K	–	401
2023 Q3	$1.59K	Buy	+166	New	+$1.59K	﹤0.01%	343
2022 Q2	–	Sell	-2,400	Closed	-$62K	–	408
2022 Q1	$62K	Buy	+2,400	New	+$62K	0.03%	160